HS
HighVista Strategies’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Sell |
57,851
-20,601
| -26% | -$1.14M | 1.18% | 14 |
|
|
2025
Q1 | $3.79M | Buy |
78,452
+15,934
| +25% | +$771K | 1.46% | 6 |
|
|
2024
Q4 | $2.41M | Sell |
62,518
-26,990
| -30% | -$1.04M | 0.9% | 30 |
|
|
2024
Q3 | $4.03M | Buy |
89,508
+68,279
| +322% | +$3.07M | 1.39% | 12 |
|
|
2024
Q2 | $736K | Hold |
21,229
| – | – | 0.27% | 106 |
|
|
2024
Q1 | $614K | Sell |
21,229
-7,130
| -25% | -$206K | 0.22% | 111 |
|
|
2023
Q4 | $650K | Buy |
+28,359
| New | +$650K | 0.24% | 107 |
|
|
2023
Q3 | – | Sell |
-29,179
| Closed | -$806K | – | 158 |
|
|
2023
Q2 | $806K | Buy |
+29,179
| New | +$806K | 0.37% | 66 |
|
|
2022
Q3 | – | Sell |
-46,459
| Closed | -$367K | – | 125 |
|
|
2022
Q2 | $367K | Sell |
46,459
-45,586
| -50% | -$360K | 0.22% | 84 |
|
|
2022
Q1 | $2.18M | Buy |
92,045
+61,046
| +197% | +$1.45M | 1.39% | 20 |
|
|
2021
Q4 | $1.06M | Buy |
30,999
+2,688
| +9% | +$91.9K | 0.84% | 42 |
|
|
2021
Q3 | $501K | Buy |
28,311
+2,458
| +10% | +$43.5K | 0.33% | 71 |
|
|
2021
Q2 | $1.16M | Buy |
+25,853
| New | +$1.16M | 0.82% | 17 |
|